IC
TECH icon

Inscription Capital’s Bio-Techne TECH Stock Holding History

Inscription Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,268
Closed -$537K – 849
2026
Q1 		$537K Sell
10,268
-7,594
-43% -$456K 0.06% 340
2025
Q4 		$1.05M Sell
17,862
-1,222
-6% -$74.3K 0.11% 181
2025
Q3 		$1.06M Buy
19,084
+12,569
+193% +$673K 0.11% 174
2025
Q2 		$335K Buy
+6,515
New +$327K 0.05% 326

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Inscription Capital's TECH Position: Q2 2026 in Review

Inscription Capital sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 10,268 shares — an estimated $537K sold.

Inscription Capital first reported a position in TECH in Q2 2025 and held it in 4 quarters. The position peaked at $1.06M in Q3 2025. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Inscription Capital reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Inscription Capital sold 10,268 Bio-Techne shares in Q2 2026, an estimated $537K.
  • Inscription Capital first reported a position in Bio-Techne in Q2 2025 and held it in 4 quarters.
  • Inscription Capital's Bio-Techne position peaked at $1.06M in Q3 2025.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.